APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Dry Eye

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Dry Eye Market Outlook and Growth Opportunities 2026

Report ID 173986690429 December 2025194 pages

Choose your research edition.

Industry ResearchDry Eye Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Dry Eye Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Dry Eye Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dry Eye Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Dry Eye Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Dry Eye market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Dry Eye is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Dry Eye is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dry Eye is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Dry Eye market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Dry Eye market include Johnson & Johnson, Novartis, United Laboratories, Jianfeng Group, URSAPHARM, Thea pharmaceuticals, Sun Pharmaceutical, SIMILASAN and Santen Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Dry Eye market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Dry Eye and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Dry Eye sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Dry Eye market size, projected growth trends, production technologies, key applications, and end-use industries.

Dry Eye Segment by Company

Johnson & Johnson

Novartis

United Laboratories

Jianfeng Group

URSAPHARM

Thea pharmaceuticals

Sun Pharmaceutical

SIMILASAN

Santen Pharma

Bausch & Lomb

Allergan

Alcon

Akorn

Dry Eye Segment by Type

Artificial Tears

Anti-inflammatory Drugs

Others

Dry Eye Segment by Application

Hospital

Retail Pharmacy

Others

Dry Eye Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Dry Eye status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Dry Eye market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Dry Eye significant trends, drivers, influence factors in global and regions.

6. To analyze Dry Eye competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dry Eye market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dry Eye and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dry Eye.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Dry Eye market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Dry Eye industry.

Chapter 3: Detailed analysis of Dry Eye manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Dry Eye in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Dry Eye in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Dry Eye Industry Trends Table 2. Dry Eye Industry Drivers Table 3. Dry Eye Industry Opportunities and Challenges Table 4. Dry Eye Industry Restraints Table 5. Global Dry Eye Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Dry Eye Revenue Share by Company (2021-2026) Table 7. Global Dry Eye Sales Volume by Company (M Units) & (2021-2026) Table 8. Global Dry Eye Sales Volume Share by Company (2021-2026) Table 9. Global Dry Eye Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Dry Eye Company Ranking, (2024-2026) & (USD Million) Table 11. Global Dry Eye Key Company Manufacturing Base & Headquarters Table 12. Global Dry Eye Company, Product Type & Application Table 13. Global Dry Eye Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Dry Eye by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Artificial Tears Table 18. Significant Companies of Anti-inflammatory Drugs Table 19. Significant Companies of Others Table 20. Global Dry Eye Sales Volume by Type 2021 VS 2025 VS 2032 (M Units) Table 21. Global Dry Eye Sales Volume by Type (2021-2026) & (M Units) Table 22. Global Dry Eye Sales Volume by Type (2027-2032) & (M Units) Table 23. Global Dry Eye Sales Volume Share by Type (2021-2026) Table 24. Global Dry Eye Sales Volume Share by Type (2027-2032) Table 25. Global Dry Eye Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Dry Eye Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Dry Eye Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Dry Eye Sales Value Share by Type (2021-2026) Table 29. Global Dry Eye Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospital Table 31. Significant Companies of Retail Pharmacy Table 32. Significant Companies of Others Table 33. Global Dry Eye Sales Volume by Application 2021 VS 2025 VS 2032 (M Units) Table 34. Global Dry Eye Sales Volume by Application (2021-2026) & (M Units) Table 35. Global Dry Eye Sales Volume by Application (2027-2032) & (M Units) Table 36. Global Dry Eye Sales Volume Share by Application (2021-2026) Table 37. Global Dry Eye Sales Volume Share by Application (2027-2032) Table 38. Global Dry Eye Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Dry Eye Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Dry Eye Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Dry Eye Sales Value Share by Application (2021-2026) Table 42. Global Dry Eye Sales Value Share by Application (2027-2032) Table 43. Global Dry Eye Sales by Region: 2021 VS 2025 VS 2032 (M Units) Table 44. Global Dry Eye Sales by Region (2021-2026) & (M Units) Table 45. Global Dry Eye Sales Market Share by Region (2021-2026) Table 46. Global Dry Eye Sales by Region (2027-2032) & (M Units) Table 47. Global Dry Eye Sales Market Share by Region (2027-2032) Table 48. Global Dry Eye Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Dry Eye Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Dry Eye Sales Value Share by Region (2021-2026) Table 51. Global Dry Eye Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Dry Eye Sales Value Share by Region (2027-2032) Table 53. Global Dry Eye Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Dry Eye Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Dry Eye Sales by Country: 2021 VS 2025 VS 2032 (M Units) Table 56. Global Dry Eye Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Dry Eye Sales by Country (2021-2026) & (M Units) Table 58. Global Dry Eye Sales Market Share by Country (2021-2026) Table 59. Global Dry Eye Sales by Country (2027-2032) & (M Units) Table 60. Global Dry Eye Sales Market Share by Country (2027-2032) Table 61. Global Dry Eye Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Dry Eye Sales Value Market Share by Country (2021-2026) Table 63. Global Dry Eye Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Dry Eye Sales Value Market Share by Country (2027-2032) Table 65. Johnson & Johnson Company Information Table 66. Johnson & Johnson Business Overview Table 67. Johnson & Johnson Dry Eye Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Johnson & Johnson Dry Eye Product Portfolio Table 69. Johnson & Johnson Recent Development Table 70. Novartis Company Information Table 71. Novartis Business Overview Table 72. Novartis Dry Eye Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Novartis Dry Eye Product Portfolio Table 74. Novartis Recent Development Table 75. United Laboratories Company Information Table 76. United Laboratories Business Overview Table 77. United Laboratories Dry Eye Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. United Laboratories Dry Eye Product Portfolio Table 79. United Laboratories Recent Development Table 80. Jianfeng Group Company Information Table 81. Jianfeng Group Business Overview Table 82. Jianfeng Group Dry Eye Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Jianfeng Group Dry Eye Product Portfolio Table 84. Jianfeng Group Recent Development Table 85. URSAPHARM Company Information Table 86. URSAPHARM Business Overview Table 87. URSAPHARM Dry Eye Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. URSAPHARM Dry Eye Product Portfolio Table 89. URSAPHARM Recent Development Table 90. Thea pharmaceuticals Company Information Table 91. Thea pharmaceuticals Business Overview Table 92. Thea pharmaceuticals Dry Eye Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Thea pharmaceuticals Dry Eye Product Portfolio Table 94. Thea pharmaceuticals Recent Development Table 95. Sun Pharmaceutical Company Information Table 96. Sun Pharmaceutical Business Overview Table 97. Sun Pharmaceutical Dry Eye Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Sun Pharmaceutical Dry Eye Product Portfolio Table 99. Sun Pharmaceutical Recent Development Table 100. SIMILASAN Company Information Table 101. SIMILASAN Business Overview Table 102. SIMILASAN Dry Eye Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. SIMILASAN Dry Eye Product Portfolio Table 104. SIMILASAN Recent Development Table 105. Santen Pharma Company Information Table 106. Santen Pharma Business Overview Table 107. Santen Pharma Dry Eye Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Santen Pharma Dry Eye Product Portfolio Table 109. Santen Pharma Recent Development Table 110. Bausch & Lomb Company Information Table 111. Bausch & Lomb Business Overview Table 112. Bausch & Lomb Dry Eye Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Bausch & Lomb Dry Eye Product Portfolio Table 114. Bausch & Lomb Recent Development Table 115. Allergan Company Information Table 116. Allergan Business Overview Table 117. Allergan Dry Eye Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Allergan Dry Eye Product Portfolio Table 119. Allergan Recent Development Table 120. Alcon Company Information Table 121. Alcon Business Overview Table 122. Alcon Dry Eye Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Alcon Dry Eye Product Portfolio Table 124. Alcon Recent Development Table 125. Akorn Company Information Table 126. Akorn Business Overview Table 127. Akorn Dry Eye Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. Akorn Dry Eye Product Portfolio Table 129. Akorn Recent Development Table 130. Key Raw Materials Table 131. Raw Materials Key Suppliers Table 132. Dry Eye Distributors List Table 133. Dry Eye Customers List Table 134. Research Programs/Design for This Report Table 135. Authors List of This Report Table 136. Secondary Sources Table 137. Primary Sources List of Figures Figure 1. Dry Eye Product Image Figure 2. Global Dry Eye Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dry Eye Sales Value (2021-2032) & (US$ Million) Figure 4. Global Dry Eye Sales (2021-2032) & (M Units) Figure 5. Global Dry Eye Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Dry Eye Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Artificial Tears Image Figure 10. Anti-inflammatory Drugs Image Figure 11. Others Image Figure 12. Global Dry Eye Sales Volume by Type (2021 VS 2025 VS 2032) & (M Units) Figure 13. Global Dry Eye Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Dry Eye Sales Volume Share by Type (2021-2032) Figure 15. Global Dry Eye Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Dry Eye Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Dry Eye Sales Value Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Retail Pharmacy Image Figure 20. Others Image Figure 21. Global Dry Eye Sales Volume by Application (2021 VS 2025 VS 2032) & (M Units) Figure 22. Global Dry Eye Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Dry Eye Sales Volume Share by Application (2021-2032) Figure 24. Global Dry Eye Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Dry Eye Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Dry Eye Sales Value Share by Application (2021-2032) Figure 27. Global Dry Eye Sales by Region: 2021 VS 2025 VS 2032 (M Units) Figure 28. Global Dry Eye Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Dry Eye Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Dry Eye Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Dry Eye Sales Value (2021-2032) & (US$ Million) Figure 32. North America Dry Eye Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Dry Eye Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Dry Eye Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Dry Eye Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Dry Eye Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Dry Eye Sales Value (2021-2032) & (US$ Million) Figure 38. South America Dry Eye Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Dry Eye Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Dry Eye Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Dry Eye Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Dry Eye Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Dry Eye Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Dry Eye Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Dry Eye Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Dry Eye Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Dry Eye Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Dry Eye Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Dry Eye Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Dry Eye Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Dry Eye Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Dry Eye Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Dry Eye Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Dry Eye Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Dry Eye Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Dry Eye Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Dry Eye Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Dry Eye Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Dry Eye Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Dry Eye Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Dry Eye Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Dry Eye Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Dry Eye Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Dry Eye Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Dry Eye Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Dry Eye Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Dry Eye Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Dry Eye Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Dry Eye Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Dry Eye Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Dry Eye Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Dry Eye Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Dry Eye Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Dry Eye Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Dry Eye Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Dry Eye Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Dry Eye Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Dry Eye Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Dry Eye Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Dry Eye Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Dry Eye Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Dry Eye Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Dry Eye Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Dry Eye Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Dry Eye Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Dry Eye Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Dry Eye Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Dry Eye Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Dry Eye Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Dry Eye Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Dry Eye Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Dry Eye Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Dry Eye Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Dry Eye Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Dry Eye Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Dry Eye Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Dry Eye Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Dry Eye Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Dry Eye Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Dry Eye Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Dry Eye Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Dry Eye Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Dry Eye Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Dry Eye Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Dry Eye Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Dry Eye Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Dry Eye Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Dry Eye Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Dry Eye Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Dry Eye Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Dry Eye Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Dry Eye Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Dry Eye Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Dry Eye Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Dry Eye Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Dry Eye Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Dry Eye Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Dry Eye Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Dry Eye Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Dry Eye Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Dry Eye Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Dry Eye Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Dry Eye Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Dry Eye Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Dry Eye Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Dry Eye Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Artificial Tears
  • Anti-inflammatory Drugs
  • Others
Applications
  • Hospital
  • Retail Pharmacy
  • Others
Companies covered
  • Johnson & Johnson
  • Novartis
  • United Laboratories
  • Jianfeng Group
  • URSAPHARM
  • Thea pharmaceuticals
  • Sun Pharmaceutical
  • SIMILASAN
  • Santen Pharma
  • Bausch & Lomb
  • Allergan
  • Alcon
  • Akorn

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Dry Eye Sales Value (2021-2032)
  4. 1.2.2 Global Dry Eye Sales Volume (2021-2032)
  5. 1.2.3 Global Dry Eye Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Dry Eye Market Dynamics
  1. 2.1 Dry Eye Industry Trends
  2. 2.2 Dry Eye Industry Drivers
  3. 2.3 Dry Eye Industry Opportunities and Challenges
  4. 2.4 Dry Eye Industry Restraints
3 Dry Eye Market by Company
  1. 3.1 Global Dry Eye Company Revenue Ranking in 2025
  2. 3.2 Global Dry Eye Revenue by Company (2021-2026)
  3. 3.3 Global Dry Eye Sales Volume by Company (2021-2026)
  4. 3.4 Global Dry Eye Average Price by Company (2021-2026)
  5. 3.5 Global Dry Eye Company Ranking (2024-2026)
  6. 3.6 Global Dry Eye Company Manufacturing Base and Headquarters
  7. 3.7 Global Dry Eye Company Product Type and Application
  8. 3.8 Global Dry Eye Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Dry Eye Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Dry Eye Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Dry Eye Market by Type
  1. 4.1 Dry Eye Type Introduction
  2. 4.1.1 Artificial Tears
  3. 4.1.2 Anti-inflammatory Drugs
  4. 4.1.3 Others
  5. 4.2 Global Dry Eye Sales Volume by Type
  6. 4.2.1 Global Dry Eye Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Dry Eye Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Dry Eye Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Dry Eye Sales Value by Type
  10. 4.3.1 Global Dry Eye Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Dry Eye Sales Value by Type (2021-2032)
  12. 4.3.3 Global Dry Eye Sales Value Share by Type (2021-2032)
5 Dry Eye Market by Application
  1. 5.1 Dry Eye Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Retail Pharmacy
  4. 5.1.3 Others
  5. 5.2 Global Dry Eye Sales Volume by Application
  6. 5.2.1 Global Dry Eye Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Dry Eye Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Dry Eye Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Dry Eye Sales Value by Application
  10. 5.3.1 Global Dry Eye Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Dry Eye Sales Value by Application (2021-2032)
  12. 5.3.3 Global Dry Eye Sales Value Share by Application (2021-2032)
6 Dry Eye Regional Sales and Value Analysis
  1. 6.1 Global Dry Eye Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Dry Eye Sales by Region (2021-2032)
  3. 6.2.1 Global Dry Eye Sales by Region: 2021-2026
  4. 6.2.2 Global Dry Eye Sales by Region (2027-2032)
  5. 6.3 Global Dry Eye Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Dry Eye Sales Value by Region (2021-2032)
  7. 6.4.1 Global Dry Eye Sales Value by Region: 2021-2026
  8. 6.4.2 Global Dry Eye Sales Value by Region (2027-2032)
  9. 6.5 Global Dry Eye Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Dry Eye Sales Value (2021-2032)
  12. 6.6.2 North America Dry Eye Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Dry Eye Sales Value (2021-2032)
  15. 6.7.2 Europe Dry Eye Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Dry Eye Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Dry Eye Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Dry Eye Sales Value (2021-2032)
  21. 6.9.2 South America Dry Eye Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Dry Eye Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Dry Eye Sales Value Share by Country, 2025 VS 2032
7 Dry Eye Country-level Sales and Value Analysis
  1. 7.1 Global Dry Eye Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Dry Eye Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Dry Eye Sales by Country (2021-2032)
  4. 7.3.1 Global Dry Eye Sales by Country (2021-2026)
  5. 7.3.2 Global Dry Eye Sales by Country (2027-2032)
  6. 7.4 Global Dry Eye Sales Value by Country (2021-2032)
  7. 7.4.1 Global Dry Eye Sales Value by Country (2021-2026)
  8. 7.4.2 Global Dry Eye Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Dry Eye Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Dry Eye Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Dry Eye Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Dry Eye Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Dry Eye Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Dry Eye Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Dry Eye Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Dry Eye Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Dry Eye Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Dry Eye Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Dry Eye Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Dry Eye Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Dry Eye Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Dry Eye Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Dry Eye Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Dry Eye Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Dry Eye Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Dry Eye Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Dry Eye Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Dry Eye Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Dry Eye Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Dry Eye Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Dry Eye Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Dry Eye Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Dry Eye Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Dry Eye Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Dry Eye Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Dry Eye Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Dry Eye Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Dry Eye Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Dry Eye Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Dry Eye Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Dry Eye Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Dry Eye Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Dry Eye Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Dry Eye Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Dry Eye Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Dry Eye Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Dry Eye Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Dry Eye Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Dry Eye Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Dry Eye Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Dry Eye Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Dry Eye Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Dry Eye Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Dry Eye Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Dry Eye Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Dry Eye Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Dry Eye Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Dry Eye Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Dry Eye Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Dry Eye Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Dry Eye Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Dry Eye Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Dry Eye Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Dry Eye Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Dry Eye Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Dry Eye Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Dry Eye Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Dry Eye Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Dry Eye Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Dry Eye Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Dry Eye Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Dry Eye Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Dry Eye Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Dry Eye Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Dry Eye Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Dry Eye Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Dry Eye Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Dry Eye Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Dry Eye Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Dry Eye Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Dry Eye Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Dry Eye Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Dry Eye Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Dry Eye Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Dry Eye Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Dry Eye Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Dry Eye Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Dry Eye Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Dry Eye Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Dry Eye Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Dry Eye Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Dry Eye Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Johnson & Johnson
  2. 8.1.1 Johnson & Johnson Company Information
  3. 8.1.2 Johnson & Johnson Business Overview
  4. 8.1.3 Johnson & Johnson Dry Eye Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Johnson & Johnson Dry Eye Product Portfolio
  6. 8.1.5 Johnson & Johnson Recent Developments
  7. 8.2 Novartis
  8. 8.2.1 Novartis Company Information
  9. 8.2.2 Novartis Business Overview
  10. 8.2.3 Novartis Dry Eye Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Novartis Dry Eye Product Portfolio
  12. 8.2.5 Novartis Recent Developments
  13. 8.3 United Laboratories
  14. 8.3.1 United Laboratories Company Information
  15. 8.3.2 United Laboratories Business Overview
  16. 8.3.3 United Laboratories Dry Eye Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 United Laboratories Dry Eye Product Portfolio
  18. 8.3.5 United Laboratories Recent Developments
  19. 8.4 Jianfeng Group
  20. 8.4.1 Jianfeng Group Company Information
  21. 8.4.2 Jianfeng Group Business Overview
  22. 8.4.3 Jianfeng Group Dry Eye Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Jianfeng Group Dry Eye Product Portfolio
  24. 8.4.5 Jianfeng Group Recent Developments
  25. 8.5 URSAPHARM
  26. 8.5.1 URSAPHARM Company Information
  27. 8.5.2 URSAPHARM Business Overview
  28. 8.5.3 URSAPHARM Dry Eye Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 URSAPHARM Dry Eye Product Portfolio
  30. 8.5.5 URSAPHARM Recent Developments
  31. 8.6 Thea pharmaceuticals
  32. 8.6.1 Thea pharmaceuticals Company Information
  33. 8.6.2 Thea pharmaceuticals Business Overview
  34. 8.6.3 Thea pharmaceuticals Dry Eye Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Thea pharmaceuticals Dry Eye Product Portfolio
  36. 8.6.5 Thea pharmaceuticals Recent Developments
  37. 8.7 Sun Pharmaceutical
  38. 8.7.1 Sun Pharmaceutical Company Information
  39. 8.7.2 Sun Pharmaceutical Business Overview
  40. 8.7.3 Sun Pharmaceutical Dry Eye Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Sun Pharmaceutical Dry Eye Product Portfolio
  42. 8.7.5 Sun Pharmaceutical Recent Developments
  43. 8.8 SIMILASAN
  44. 8.8.1 SIMILASAN Company Information
  45. 8.8.2 SIMILASAN Business Overview
  46. 8.8.3 SIMILASAN Dry Eye Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 SIMILASAN Dry Eye Product Portfolio
  48. 8.8.5 SIMILASAN Recent Developments
  49. 8.9 Santen Pharma
  50. 8.9.1 Santen Pharma Company Information
  51. 8.9.2 Santen Pharma Business Overview
  52. 8.9.3 Santen Pharma Dry Eye Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Santen Pharma Dry Eye Product Portfolio
  54. 8.9.5 Santen Pharma Recent Developments
  55. 8.10 Bausch & Lomb
  56. 8.10.1 Bausch & Lomb Company Information
  57. 8.10.2 Bausch & Lomb Business Overview
  58. 8.10.3 Bausch & Lomb Dry Eye Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Bausch & Lomb Dry Eye Product Portfolio
  60. 8.10.5 Bausch & Lomb Recent Developments
  61. 8.11 Allergan
  62. 8.11.1 Allergan Company Information
  63. 8.11.2 Allergan Business Overview
  64. 8.11.3 Allergan Dry Eye Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Allergan Dry Eye Product Portfolio
  66. 8.11.5 Allergan Recent Developments
  67. 8.12 Alcon
  68. 8.12.1 Alcon Company Information
  69. 8.12.2 Alcon Business Overview
  70. 8.12.3 Alcon Dry Eye Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Alcon Dry Eye Product Portfolio
  72. 8.12.5 Alcon Recent Developments
  73. 8.13 Akorn
  74. 8.13.1 Akorn Company Information
  75. 8.13.2 Akorn Business Overview
  76. 8.13.3 Akorn Dry Eye Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Akorn Dry Eye Product Portfolio
  78. 8.13.5 Akorn Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Dry Eye Value Chain Analysis
  2. 9.1.1 Dry Eye Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Dry Eye Sales Mode & Process
  6. 9.2 Dry Eye Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Dry Eye Distributors
  9. 9.2.3 Dry Eye Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst